SYMBOTIC INC (SYM)

US87151X1019 - Common Stock

46.16  -0.52 (-1.11%)

After market: 46 -0.16 (-0.35%)

Fundamental Rating

4

Overall SYM gets a fundamental rating of 4 out of 10. We evaluated SYM against 132 industry peers in the Machinery industry. While SYM seems to be doing ok healthwise, there are quite some concerns on its profitability. SYM is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

SYM had negative earnings in the past year.
SYM had a positive operating cash flow in the past year.
SYM had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SYM reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of SYM (-1.40%) is worse than 70.77% of its industry peers.
SYM's Return On Equity of -11.54% is on the low side compared to the rest of the industry. SYM is outperformed by 71.54% of its industry peers.
Industry RankSector Rank
ROA -1.4%
ROE -11.54%
ROIC N/A
ROA(3y)-19.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 16.77%, SYM is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
SYM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
SYM has more shares outstanding than it did 1 year ago.
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SYM has an Altman-Z score of 13.35. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 13.35, SYM belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.35
ROIC/WACCN/A
WACC9.12%

2.3 Liquidity

A Current Ratio of 1.15 indicates that SYM should not have too much problems paying its short term obligations.
The Current ratio of SYM (1.15) is worse than 86.15% of its industry peers.
SYM has a Quick Ratio of 1.02. This is a normal value and indicates that SYM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.02, SYM is doing worse than 63.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.02

7

3. Growth

3.1 Past

The earnings per share for SYM have decreased strongly by -180.56% in the last year.
SYM shows a strong growth in Revenue. In the last year, the Revenue has grown by 85.31%.
SYM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 133.79% yearly.
EPS 1Y (TTM)-180.56%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q77.78%
Revenue 1Y (TTM)85.31%
Revenue growth 3Y133.79%
Revenue growth 5YN/A
Revenue growth Q2Q78.6%

3.2 Future

The Earnings Per Share is expected to grow by 56.62% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 47.10% on average over the next years. This is a very strong growth
EPS Next Y167.05%
EPS Next 2Y76.96%
EPS Next 3Y56.62%
EPS Next 5YN/A
Revenue Next Year38.53%
Revenue Next 2Y50.61%
Revenue Next 3Y47.1%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SYM. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 106.29 indicates a quite expensive valuation of SYM.
66.92% of the companies in the same industry are cheaper than SYM, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.47. SYM is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 106.29

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SYM indicates a slightly more expensive valuation: SYM is more expensive than 63.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 303.02
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SYM's earnings are expected to grow with 56.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.96%
EPS Next 3Y56.62%

0

5. Dividend

5.1 Amount

SYM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SYMBOTIC INC

NASDAQ:SYM (5/16/2024, 7:19:41 PM)

After market: 46 -0.16 (-0.35%)

46.16

-0.52 (-1.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.87B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 106.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -11.54%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.77%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.15
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-180.56%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y167.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)85.31%
Revenue growth 3Y133.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y